期刊文献+

阿苯达唑脂质体中磷脂含量测定 被引量:5

Visible spectrophotometry analysis of phospholipid in oral liposomal albendazole
下载PDF
导出
摘要 目的:建立阿苯达唑脂质体中磷脂含量的测定方法。 方法:利用可见分光光度法测定 ,检测波长 4 85nm。结果 :磷脂在 0 .0 1~ 0 .1mg/ m l浓度范围内呈现良好的线性关系 (r =0 .9993) ,平均回收率为 99.84 %。结论 :本方法灵敏、准确、简便 ,不受阿苯达唑共存的干扰 。 Objective: To establish a method of determining the concentration of phospholipid in oral liposomal albendazole (L ABZ). Method: The concentration of phospholipid in oral liposomal albendazole was determined with visible spectrophotometry, the determination wavelength was 485 nm. Result: The method was linear between phospholipid concentration of 0.01~0.1 mg/ml, the standard regessive curve was C(mg/ml)=0.412 0 A-0.002 8, r=0.999 3. The average recovery rate was 99.84%. Conclusion: The results showed that this method could eliminate the interference of albendazole. The method is simple, rapid and accurate.
出处 《新疆医科大学学报》 CAS 2002年第2期119-120,共2页 Journal of Xinjiang Medical University
基金 国家九五攻关项目 (96-90 6-A-0 4-0 9) 国家自然科学基金项目 (3 9660 0 81
关键词 阿苯达唑脂质体 磷脂 含量测定 可见分光光度法 phospholipid albendazole liposomal visible spectrophotometry
  • 相关文献

参考文献1

  • 1奚念珠 等.药剂学(第3版)[M].北京:人民卫生出版社,1994,7.271.

共引文献3

同被引文献43

  • 1易学文,吴霞.免疫脂质体的研究进展[J].四川理工学院学报(自然科学版),2004,17(3):133-136. 被引量:4
  • 2王建华,温浩,买尔旦.阿苯达唑脂质体的包封率测定及形态观察[J].新疆医学院学报,1994,17(1):18-21. 被引量:9
  • 3姚淑娟,刘伯阳,吕丽艳.榄香烯提高肿瘤化疗药物疗效及抗免疫抑制作用的研究[J].中医药学刊,2006,24(3):456-457. 被引量:17
  • 4胡佳惠,马国营,张喜玲,刘德强.阿霉素脂质体中磷脂含量测定[J].西北药学杂志,1996,11(5):195-196. 被引量:4
  • 5de Herder WW, van der Lely A J, Lamberts SW. Somatostatin analogue treatment of neuroendocrine tumours [ J ]. Postgrad Med J, 1996,72 ( 848 ) :403 - 408.
  • 6Huang CM, Wu YT, Chen ST. Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis [ J ]. Chem Biol, 2000,7(7 ) :453 -461.
  • 7Guillermet-Guibert J, Lahlou H, Pyronnet S, et al. Somatostatin receptors as tools for diagnosis and therapy: Molecular aspects [J]. Best Pract Res Cl Ga,2005,19(4) :535 -551.
  • 8Anthony CT,Hughey S,Lyons J,et al. The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs [ J ]. J Surg Res, 2004, 119(1):1 -13.
  • 9Zhang J,Jin W,Wang X,et al. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models[ J]. Mol Pharm,2010, 7(4):1 159-1 168.
  • 10Nagy A, Schally AV, Halmos G, et al. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin [J]. Proc Natl Acad Sci USA,1998,95(4) :1 794 -1 799.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部